T1	Participants 24 62	non-nephrotic syndrome IgA nephropathy
T2	Participants 148 193	non-nephrotic syndrome IgA nephropathy (IgAN)
T3	Participants 203 232	Seventy primary IgAN patients
T4	Participants 1295 1299	IgAN
